Valerie Mandriota Banner-Goodspeed, M.P.H.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Insufficiency | 7 | 2023 | 1241 | 0.750 |
Why?
|
| Respiration, Artificial | 9 | 2023 | 2721 | 0.500 |
Why?
|
| Cardiac Surgical Procedures | 7 | 2022 | 3681 | 0.410 |
Why?
|
| Propofol | 4 | 2022 | 608 | 0.400 |
Why?
|
| Delirium | 5 | 2022 | 1695 | 0.380 |
Why?
|
| Survivors | 7 | 2023 | 2382 | 0.350 |
Why?
|
| Ventilator-Induced Lung Injury | 2 | 2021 | 135 | 0.340 |
Why?
|
| Critical Illness | 7 | 2022 | 2755 | 0.330 |
Why?
|
| Hospital Mortality | 7 | 2022 | 5367 | 0.310 |
Why?
|
| Anesthesia, Conduction | 2 | 2022 | 263 | 0.290 |
Why?
|
| Positive-Pressure Respiration | 3 | 2021 | 713 | 0.290 |
Why?
|
| Patient Discharge | 5 | 2023 | 3476 | 0.270 |
Why?
|
| Intensive Care Units | 10 | 2023 | 3801 | 0.270 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2021 | 417 | 0.260 |
Why?
|
| Lung Injury | 2 | 2022 | 433 | 0.260 |
Why?
|
| Anesthetics, Inhalation | 2 | 2022 | 573 | 0.250 |
Why?
|
| Heme | 2 | 2023 | 316 | 0.210 |
Why?
|
| Neuromuscular Blockade | 2 | 2021 | 148 | 0.200 |
Why?
|
| Survival | 1 | 2021 | 160 | 0.190 |
Why?
|
| Methyl Ethers | 1 | 2022 | 196 | 0.180 |
Why?
|
| Neutrophils | 2 | 2023 | 3785 | 0.170 |
Why?
|
| Esophagus | 3 | 2021 | 1042 | 0.170 |
Why?
|
| Oxygen | 3 | 2021 | 4273 | 0.160 |
Why?
|
| Embolism, Paradoxical | 1 | 2019 | 55 | 0.160 |
Why?
|
| Enoxaparin | 1 | 2021 | 391 | 0.150 |
Why?
|
| Relaxation Therapy | 1 | 2019 | 181 | 0.150 |
Why?
|
| Acetaminophen | 2 | 2021 | 556 | 0.150 |
Why?
|
| Hypnotics and Sedatives | 3 | 2022 | 1188 | 0.150 |
Why?
|
| Dissent and Disputes | 1 | 2019 | 150 | 0.150 |
Why?
|
| Hospitalization | 6 | 2023 | 10844 | 0.140 |
Why?
|
| Intraoperative Complications | 1 | 2024 | 1176 | 0.140 |
Why?
|
| Critical Care | 3 | 2023 | 2716 | 0.140 |
Why?
|
| Thrombosis | 2 | 2021 | 2955 | 0.140 |
Why?
|
| Health Services Misuse | 1 | 2019 | 249 | 0.140 |
Why?
|
| Intraoperative Care | 1 | 2021 | 771 | 0.140 |
Why?
|
| Hypothyroidism | 1 | 2022 | 669 | 0.140 |
Why?
|
| Registries | 3 | 2022 | 8379 | 0.140 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 426 | 0.130 |
Why?
|
| Blood Gas Analysis | 1 | 2017 | 384 | 0.130 |
Why?
|
| Respiration | 1 | 2023 | 1667 | 0.130 |
Why?
|
| Foramen Ovale, Patent | 1 | 2019 | 210 | 0.130 |
Why?
|
| Virus Diseases | 1 | 2022 | 723 | 0.130 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2019 | 1097 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2023 | 985 | 0.130 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2021 | 1163 | 0.130 |
Why?
|
| Hyperoxia | 1 | 2017 | 261 | 0.130 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2019 | 371 | 0.130 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2017 | 347 | 0.130 |
Why?
|
| Postoperative Complications | 4 | 2024 | 15881 | 0.130 |
Why?
|
| Professional-Family Relations | 1 | 2019 | 501 | 0.120 |
Why?
|
| Cholecalciferol | 1 | 2019 | 557 | 0.120 |
Why?
|
| Quality of Life | 5 | 2023 | 13503 | 0.120 |
Why?
|
| Dexmedetomidine | 1 | 2019 | 320 | 0.120 |
Why?
|
| Heparin | 1 | 2021 | 1636 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2021 | 1397 | 0.110 |
Why?
|
| Nurses | 1 | 2023 | 2494 | 0.110 |
Why?
|
| Cognition | 3 | 2020 | 7075 | 0.100 |
Why?
|
| Adult | 25 | 2024 | 223640 | 0.100 |
Why?
|
| Humans | 49 | 2024 | 768393 | 0.100 |
Why?
|
| Aged | 22 | 2024 | 171562 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2020 | 1045 | 0.100 |
Why?
|
| Length of Stay | 6 | 2023 | 6519 | 0.100 |
Why?
|
| Patient Preference | 1 | 2019 | 947 | 0.090 |
Why?
|
| Vitamins | 1 | 2019 | 1637 | 0.090 |
Why?
|
| Monitoring, Intraoperative | 1 | 2017 | 950 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2021 | 2240 | 0.090 |
Why?
|
| Double-Blind Method | 6 | 2021 | 12456 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2021 | 10377 | 0.090 |
Why?
|
| Pneumonia | 1 | 2022 | 2163 | 0.090 |
Why?
|
| Terminal Care | 1 | 2022 | 1773 | 0.090 |
Why?
|
| Inpatients | 1 | 2022 | 2570 | 0.090 |
Why?
|
| Middle Aged | 22 | 2024 | 223491 | 0.090 |
Why?
|
| Vitamin D Deficiency | 1 | 2019 | 1389 | 0.090 |
Why?
|
| Orthopedic Procedures | 1 | 2019 | 1280 | 0.080 |
Why?
|
| Prospective Studies | 10 | 2023 | 54920 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 1943 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2021 | 3461 | 0.080 |
Why?
|
| Aspirin | 2 | 2022 | 3135 | 0.080 |
Why?
|
| Wounds and Injuries | 1 | 2021 | 2514 | 0.080 |
Why?
|
| Cohort Studies | 8 | 2024 | 41795 | 0.080 |
Why?
|
| Male | 26 | 2024 | 364902 | 0.080 |
Why?
|
| Coronary Artery Bypass | 1 | 2017 | 2194 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 1890 | 0.070 |
Why?
|
| Anesthetics, Intravenous | 2 | 2022 | 397 | 0.070 |
Why?
|
| Pandemics | 3 | 2022 | 8753 | 0.070 |
Why?
|
| Female | 25 | 2024 | 397089 | 0.070 |
Why?
|
| Boston | 4 | 2021 | 9371 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2276 | 0.070 |
Why?
|
| Health Status | 1 | 2019 | 4094 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2019 | 3008 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 2 | 2021 | 1727 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2021 | 4843 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 3413 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3922 | 0.060 |
Why?
|
| Physicians | 1 | 2023 | 4614 | 0.060 |
Why?
|
| Anxiety | 1 | 2019 | 4677 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2019 | 9379 | 0.060 |
Why?
|
| Drug Therapy, Combination | 3 | 2019 | 6318 | 0.060 |
Why?
|
| Treatment Failure | 2 | 2020 | 2663 | 0.060 |
Why?
|
| Rwanda | 2 | 2016 | 669 | 0.050 |
Why?
|
| Severity of Illness Index | 4 | 2022 | 15939 | 0.050 |
Why?
|
| Motivation | 2 | 2023 | 2029 | 0.050 |
Why?
|
| Immersion | 1 | 2022 | 37 | 0.050 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2023 | 199 | 0.050 |
Why?
|
| Retrospective Studies | 7 | 2024 | 81801 | 0.050 |
Why?
|
| Partial Thromboplastin Time | 1 | 2021 | 204 | 0.050 |
Why?
|
| Fibrinolytic Agents | 2 | 2021 | 2074 | 0.040 |
Why?
|
| Neostigmine | 1 | 2020 | 68 | 0.040 |
Why?
|
| Clinical Protocols | 2 | 2017 | 1445 | 0.040 |
Why?
|
| Aged, 80 and over | 6 | 2022 | 59686 | 0.040 |
Why?
|
| Prone Position | 1 | 2021 | 203 | 0.040 |
Why?
|
| Risk Factors | 7 | 2022 | 74962 | 0.040 |
Why?
|
| Resuscitation Orders | 1 | 2022 | 271 | 0.040 |
Why?
|
| Tidal Volume | 1 | 2022 | 515 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2022 | 307 | 0.040 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 1482 | 0.040 |
Why?
|
| Sex Factors | 2 | 2024 | 10654 | 0.040 |
Why?
|
| Treatment Outcome | 7 | 2021 | 65379 | 0.040 |
Why?
|
| Time | 1 | 2021 | 546 | 0.040 |
Why?
|
| Hospitals | 2 | 2023 | 3906 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2021 | 283 | 0.040 |
Why?
|
| Patient Positioning | 1 | 2021 | 332 | 0.040 |
Why?
|
| Chemokines | 1 | 2022 | 962 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2020 | 5313 | 0.040 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2019 | 192 | 0.040 |
Why?
|
| Patient Readmission | 2 | 2023 | 3312 | 0.040 |
Why?
|
| Oximetry | 1 | 2021 | 462 | 0.040 |
Why?
|
| Partial Pressure | 1 | 2017 | 248 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 871 | 0.040 |
Why?
|
| Perioperative Period | 1 | 2019 | 252 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2021 | 657 | 0.040 |
Why?
|
| Comorbidity | 2 | 2022 | 10588 | 0.030 |
Why?
|
| Hand | 1 | 2022 | 912 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2021 | 990 | 0.030 |
Why?
|
| Stroke | 1 | 2019 | 9742 | 0.030 |
Why?
|
| Time Factors | 4 | 2020 | 40272 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2022 | 2931 | 0.030 |
Why?
|
| Creatinine | 1 | 2022 | 1915 | 0.030 |
Why?
|
| Age Distribution | 1 | 2022 | 2877 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 2106 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 1855 | 0.030 |
Why?
|
| Actins | 1 | 2023 | 2059 | 0.030 |
Why?
|
| Pressure | 1 | 2019 | 1172 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2023 | 14784 | 0.030 |
Why?
|
| Social Perception | 1 | 2019 | 433 | 0.030 |
Why?
|
| Lung | 3 | 2022 | 10089 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 417 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2021 | 1161 | 0.030 |
Why?
|
| Mental Recall | 1 | 2021 | 1226 | 0.030 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 3836 | 0.030 |
Why?
|
| Leukocytes | 1 | 2022 | 2030 | 0.030 |
Why?
|
| United States | 5 | 2023 | 73150 | 0.030 |
Why?
|
| Incidence | 3 | 2019 | 21544 | 0.030 |
Why?
|
| Hospitals, Public | 1 | 2016 | 205 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2017 | 1169 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2022 | 2866 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2023 | 2433 | 0.030 |
Why?
|
| Age Factors | 2 | 2022 | 18471 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2019 | 799 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 1422 | 0.030 |
Why?
|
| Anesthesia | 1 | 2024 | 1596 | 0.030 |
Why?
|
| Research Design | 2 | 2019 | 6210 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2019 | 1095 | 0.030 |
Why?
|
| Social Support | 1 | 2022 | 2191 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2019 | 1480 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2021 | 22296 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 1765 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2168 | 0.020 |
Why?
|
| Demography | 1 | 2016 | 1642 | 0.020 |
Why?
|
| Peptides | 1 | 2023 | 4353 | 0.020 |
Why?
|
| Probability | 1 | 2016 | 2482 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 2736 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 4357 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2021 | 2990 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 26375 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2019 | 2025 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2021 | 3131 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2020 | 2693 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2022 | 9682 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39407 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6541 | 0.020 |
Why?
|
| Adolescent | 3 | 2022 | 89184 | 0.020 |
Why?
|
| Young Adult | 3 | 2021 | 60049 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 3486 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2783 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2021 | 4339 | 0.020 |
Why?
|
| Vitamin D | 1 | 2019 | 3310 | 0.020 |
Why?
|
| Contrast Media | 1 | 2019 | 5336 | 0.020 |
Why?
|
| Mice | 2 | 2023 | 82017 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 8051 | 0.020 |
Why?
|
| Mental Health | 1 | 2019 | 3276 | 0.010 |
Why?
|
| Radiography | 1 | 2016 | 6993 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2022 | 13052 | 0.010 |
Why?
|
| Poverty | 1 | 2016 | 2721 | 0.010 |
Why?
|
| Risk | 1 | 2016 | 9636 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7453 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2019 | 3858 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14737 | 0.010 |
Why?
|
| Developing Countries | 1 | 2016 | 2903 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5375 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2016 | 6001 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2016 | 5099 | 0.010 |
Why?
|
| Animals | 2 | 2023 | 169337 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 13084 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2022 | 42650 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20224 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 7955 | 0.010 |
Why?
|
| Child | 1 | 2022 | 80891 | 0.010 |
Why?
|